SCHEMBL3745112

SCHEMBL3745112

N#CC(c1ccnc(OCc2cncc(N3CCOCC3)c2)n1)c1nc2ccccc2s1

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 11/20 0.71
MAPK9 P45984 10/20 0.71
MAPK8 P45983 2/20 0.71
RAB9A P51151 4/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.35
PIK3CD O00329 1/20 0.34
ALDH1A1 P00352 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
LRRK2 Q5S007 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3751266 0.86 MAPK10 (0.74) MAPK10MAPK9MAPK8RAB9ANPC1
Bentamapimod SCHEMBL30197744 0.83 MAPK10 (1.00) MAPK10MAPK9MAPK8RAB9ANPC1
Bentamapimod SCHEMBL2878382 0.83 MAPK10 (1.00) MAPK10MAPK9MAPK8RAB9ANPC1
Bentamapimod SCHEMBL29423429 0.83 MAPK10 (1.00) MAPK10MAPK9MAPK8RAB9ANPC1
Bentamapimod SCHEMBL29350260 0.83 MAPK10 (1.00) MAPK10MAPK9MAPK8RAB9ANPC1
SCHEMBL3747858 0.83 MAPK10 (0.86) MAPK10MAPK9MAPK8RAB9ASMN1; SMN2
SCHEMBL2883226 0.81 MAPK10 (0.83) MAPK10MAPK9MAPK8RAB9ANPC1
Bentamapimod SCHEMBL4948513 0.80 MAPK10 (0.89) MAPK10MAPK9MAPK8RAB9ANPC1
SCHEMBL2881240 0.79 MAPK10 (0.88) MAPK10MAPK9MAPK8RAB9ANPC1
SCHEMBL1518907 0.79 MAPK10 (1.00) MAPK10MAPK9MAPK8RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838522-B2 Benzothiazole formulations and use thereof ARES TRADING S.A. (CH) 2010-11-23 US disclosed
US-7838522-B2 Benzothiazole formulations and use thereof ARES TRADING S.A. (CH) 2010-11-23 US disclosed
US-7838522-B2 Benzothiazole formulations and use thereof ARES TRADING S.A. (CH) 2010-11-23 US disclosed
US-20080051397-A1 Benzothiazole Formulations and Use Thereof ARES TRADING S.A. (CH) 2008-02-28 US disclosed
US-20080051397-A1 Benzothiazole Formulations and Use Thereof ARES TRADING S.A. (CH) 2008-02-28 US disclosed
US-20080051397-A1 Benzothiazole Formulations and Use Thereof ARES TRADING S.A. (CH) 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051397-A1 Benzothiazole Formulations and Use Thereof MGLL, MBOAT4, MBOAT1 MAPK10 3176/4885MAPK9 3960/4885MAPK8 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.